The U.S. Food and Drug Administration has approved GSK’s prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).
This article was originally published on MedicalXpress.com
FDA approves prefilled syringe presentation for shingles vaccine
You may also be interested in:
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Read More:
-
Oregon Health & Science University-led research is reporting that daily full-body emollient use starting before 9 weeks of age lowered atopic dermatitis incidence by 24 [...]
-
A baby born at only 21 weeks of gestation last July in Iowa City, Iowa, has just celebrated his first birthday, and among his gifts [...]
-
Fetal exposure to inflammation has long been identified as a risk factor for a range of harmful conditions, but new research suggests systemic inflammation alone [...]
